- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-1-mer
- Ligands
- 18 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 26 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.19: 2 residues within 4Å:- Chain A: Y.28, N.61
Ligand excluded by PLIPNAG.20: 3 residues within 4Å:- Chain A: N.122, T.124, V.127
Ligand excluded by PLIPNAG.21: 3 residues within 4Å:- Chain A: E.132, N.162, N.163
Ligand excluded by PLIPNAG.22: 3 residues within 4Å:- Chain A: T.108, N.232, T.234
Ligand excluded by PLIPNAG.23: 3 residues within 4Å:- Chain A: N.278, E.279, N.280
Ligand excluded by PLIPNAG.24: 3 residues within 4Å:- Chain A: N.707, G.1129
- Chain B: D.794
Ligand excluded by PLIPNAG.25: 2 residues within 4Å:- Chain B: Y.28, N.61
Ligand excluded by PLIPNAG.26: 5 residues within 4Å:- Chain B: N.122, A.123, T.124, N.125, V.127
Ligand excluded by PLIPNAG.27: 3 residues within 4Å:- Chain B: E.132, N.162, N.163
Ligand excluded by PLIPNAG.28: 3 residues within 4Å:- Chain B: T.108, N.232, T.234
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain B: N.278, E.279, N.280
Ligand excluded by PLIPNAG.30: 2 residues within 4Å:- Chain B: N.329, Q.578
Ligand excluded by PLIPNAG.31: 1 residues within 4Å:- Chain B: N.341
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain B: N.707, G.1129
- Chain C: D.794
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain C: Y.28, N.61
Ligand excluded by PLIPNAG.34: 5 residues within 4Å:- Chain C: N.122, A.123, T.124, N.125, V.127
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain C: E.132, N.162, N.163
Ligand excluded by PLIPNAG.36: 3 residues within 4Å:- Chain C: T.108, N.232, T.234
Ligand excluded by PLIPNAG.37: 3 residues within 4Å:- Chain C: N.278, E.279, N.280
Ligand excluded by PLIPNAG.38: 3 residues within 4Å:- Chain A: D.794
- Chain C: N.707, G.1129
Ligand excluded by PLIPNAG.39: 2 residues within 4Å:- Chain D: N.36, Q.323
Ligand excluded by PLIPNAG.40: 3 residues within 4Å:- Chain D: K.9, N.73, T.75
Ligand excluded by PLIPNAG.41: 5 residues within 4Å:- Chain D: Q.64, Q.84, N.86, V.90, H.178
Ligand excluded by PLIPNAG.42: 1 residues within 4Å:- Chain D: N.305
Ligand excluded by PLIPNAG.43: 2 residues within 4Å:- Chain D: N.415, W.577
Ligand excluded by PLIPNAG.44: 2 residues within 4Å:- Chain D: S.403, N.529
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Saville, J.W. et al., Structural and biochemical rationale for enhanced spike protein fitness in delta and kappa SARS-CoV-2 variants. Nat Commun (2022)
- Release Date
- 2022-03-30
- Peptides
- Spike glycoprotein: ABC
Processed angiotensin-converting enzyme 2: D - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
E
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-1-mer
- Ligands
- 18 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 26 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Saville, J.W. et al., Structural and biochemical rationale for enhanced spike protein fitness in delta and kappa SARS-CoV-2 variants. Nat Commun (2022)
- Release Date
- 2022-03-30
- Peptides
- Spike glycoprotein: ABC
Processed angiotensin-converting enzyme 2: D - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
E